Saentra Forge
  • who we are
  • our companies
  • stories
  • investors
Select Page

Una terapia genica “made in Italy” per il glioblastoma e altri tumori solidi

Mar 13, 2026

CONTACT
NEWSROOM
© 2026 Genenta Science S.p.A., doing business as Saentra Forge (Nasdaq: SAEN)
All Rights Reserved - Terms and conditions - Privacy Policy - Whistleblowing - P.IVA 08738490963